nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazepam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.0117	0.0355	CbGeAlD
Prazepam—GABRD—forebrain—attention deficit hyperactivity disorder	0.0102	0.0308	CbGeAlD
Prazepam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.00982	0.0297	CbGeAlD
Prazepam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00947	0.0286	CbGeAlD
Prazepam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00764	0.0231	CbGeAlD
Prazepam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00719	0.0217	CbGeAlD
Prazepam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00719	0.0217	CbGeAlD
Prazepam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00674	0.0204	CbGeAlD
Prazepam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00669	0.0202	CbGeAlD
Prazepam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00662	0.02	CbGeAlD
Prazepam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00657	0.0198	CbGeAlD
Prazepam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.00649	0.0196	CbGeAlD
Prazepam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00644	0.0195	CbGeAlD
Prazepam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00637	0.0193	CbGeAlD
Prazepam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00635	0.0192	CbGeAlD
Prazepam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.00629	0.019	CbGeAlD
Prazepam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.00623	0.0188	CbGeAlD
Prazepam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.00614	0.0185	CbGeAlD
Prazepam—GABRD—nervous system—attention deficit hyperactivity disorder	0.00554	0.0167	CbGeAlD
Prazepam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00552	0.0167	CbGeAlD
Prazepam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.00533	0.0161	CbGeAlD
Prazepam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.00533	0.0161	CbGeAlD
Prazepam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.00521	0.0158	CbGeAlD
Prazepam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.00517	0.0156	CbGeAlD
Prazepam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00514	0.0155	CbGeAlD
Prazepam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.00513	0.0155	CbGeAlD
Prazepam—GABRG3—brain—attention deficit hyperactivity disorder	0.00511	0.0154	CbGeAlD
Prazepam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.00502	0.0152	CbGeAlD
Prazepam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.00498	0.015	CbGeAlD
Prazepam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00495	0.015	CbGeAlD
Prazepam—GABRR1—brain—attention deficit hyperactivity disorder	0.00487	0.0147	CbGeAlD
Prazepam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.00487	0.0147	CbGeAlD
Prazepam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00479	0.0145	CbGeAlD
Prazepam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00475	0.0143	CbGeAlD
Prazepam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00475	0.0143	CbGeAlD
Prazepam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00461	0.0139	CbGeAlD
Prazepam—GABRD—brain—attention deficit hyperactivity disorder	0.00423	0.0128	CbGeAlD
Prazepam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00419	0.0127	CbGeAlD
Prazepam—GABRG1—brain—attention deficit hyperactivity disorder	0.00408	0.0123	CbGeAlD
Prazepam—GABRB1—brain—attention deficit hyperactivity disorder	0.00395	0.0119	CbGeAlD
Prazepam—GABRA5—brain—attention deficit hyperactivity disorder	0.00393	0.0119	CbGeAlD
Prazepam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.0039	0.0118	CbGeAlD
Prazepam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.0039	0.0118	CbGeAlD
Prazepam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00376	0.0114	CbGeAlD
Prazepam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00376	0.0114	CbGeAlD
Prazepam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.00367	0.0111	CbGeAlD
Prazepam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00367	0.0111	CbGeAlD
Prazepam—GABRA3—brain—attention deficit hyperactivity disorder	0.00366	0.0111	CbGeAlD
Prazepam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00365	0.011	CbGeAlD
Prazepam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00357	0.0108	CbGeAlD
Prazepam—GABRR1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00356	0.00566	CbGpPWpGaD
Prazepam—GABRE—nervous system—attention deficit hyperactivity disorder	0.00354	0.0107	CbGeAlD
Prazepam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00345	0.0104	CbGeAlD
Prazepam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00343	0.0104	CbGeAlD
Prazepam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.0034	0.0103	CbGeAlD
Prazepam—GABRR2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00339	0.0054	CbGpPWpGaD
Prazepam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00336	0.0101	CbGeAlD
Prazepam—GABRB2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00335	0.00533	CbGpPWpGaD
Prazepam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00332	0.01	CbGeAlD
Prazepam—GABRA5—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00326	0.00518	CbGpPWpGaD
Prazepam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00324	0.0098	CbGeAlD
Prazepam—GABRA3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0032	0.00509	CbGpPWpGaD
Prazepam—GABRA2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00314	0.005	CbGpPWpGaD
Prazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00314	0.00499	CbGpPWpGaD
Prazepam—GABRB3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00312	0.00497	CbGpPWpGaD
Prazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00309	0.00492	CbGpPWpGaD
Prazepam—GABRG2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00307	0.00488	CbGpPWpGaD
Prazepam—Azelastine—HRH3—attention deficit hyperactivity disorder	0.00304	0.075	CrCbGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.003	0.00478	CbGpPWpGaD
Prazepam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.003	0.00906	CbGeAlD
Prazepam—GABRB2—brain—attention deficit hyperactivity disorder	0.00298	0.00901	CbGeAlD
Prazepam—GABRG2—brain—attention deficit hyperactivity disorder	0.00298	0.00901	CbGeAlD
Prazepam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.00289	0.00872	CbGeAlD
Prazepam—GABRR2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00287	0.00456	CbGpPWpGaD
Prazepam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00282	0.00852	CbGeAlD
Prazepam—GABRG3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00279	0.00444	CbGpPWpGaD
Prazepam—GABRB1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00275	0.00438	CbGpPWpGaD
Prazepam—GABRA2—brain—attention deficit hyperactivity disorder	0.00273	0.00824	CbGeAlD
Prazepam—GABRE—brain—attention deficit hyperactivity disorder	0.0027	0.00817	CbGeAlD
Prazepam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.00269	0.0664	CrCbGaD
Prazepam—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00268	0.00426	CbGpPWpGaD
Prazepam—Nitrazepam—GABRQ—attention deficit hyperactivity disorder	0.00268	0.0659	CrCbGaD
Prazepam—GABRR2—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.00267	0.00424	CbGpPWpGaD
Prazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00264	0.0042	CbGpPWpGaD
Prazepam—GABRA1—brain—attention deficit hyperactivity disorder	0.00263	0.00796	CbGeAlD
Prazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00257	0.00408	CbGpPWpGaD
Prazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00252	0.00401	CbGpPWpGaD
Prazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00248	0.00394	CbGpPWpGaD
Prazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00246	0.00392	CbGpPWpGaD
Prazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00242	0.00384	CbGpPWpGaD
Prazepam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.00238	0.0586	CrCbGaD
Prazepam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.00238	0.0586	CrCbGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00236	0.00375	CbGpPWpGaD
Prazepam—GABRB2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00235	0.00374	CbGpPWpGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00232	0.0037	CbGpPWpGaD
Prazepam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.0023	0.0568	CrCbGaD
Prazepam—GABRR1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0023	0.00366	CbGpPWpGaD
Prazepam—GABRB3—brain—attention deficit hyperactivity disorder	0.00229	0.00692	CbGeAlD
Prazepam—GABRA5—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00228	0.00363	CbGpPWpGaD
Prazepam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.00228	0.0561	CrCbGaD
Prazepam—GABRA3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00224	0.00357	CbGpPWpGaD
Prazepam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.00221	0.0544	CrCbGaD
Prazepam—GABRA2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0022	0.00351	CbGpPWpGaD
Prazepam—GABRR2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0022	0.00349	CbGpPWpGaD
Prazepam—GABRB3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00219	0.00348	CbGpPWpGaD
Prazepam—GABRG2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00215	0.00342	CbGpPWpGaD
Prazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00211	0.00336	CbGpPWpGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00199	0.00316	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00193	0.00307	CbGpPWpGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00189	0.00301	CbGpPWpGaD
Prazepam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00189	0.0466	CrCbGaD
Prazepam—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00188	0.00299	CbGpPWpGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00186	0.00296	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00185	0.00294	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00182	0.00289	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00181	0.00288	CbGpPWpGaD
Prazepam—Mazindol—SLC6A3—attention deficit hyperactivity disorder	0.00179	0.0441	CrCbGaD
Prazepam—GABRB1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00178	0.00283	CbGpPWpGaD
Prazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00176	0.0028	CbGpPWpGaD
Prazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00168	0.00267	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00159	0.00253	CbGpPWpGaD
Prazepam—Loxapine—DRD5—attention deficit hyperactivity disorder	0.00157	0.0388	CrCbGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00154	0.00245	CbGpPWpGaD
Prazepam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00153	0.00464	CbGeAlD
Prazepam—GABRB2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00152	0.00242	CbGpPWpGaD
Prazepam—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.00148	0.0366	CrCbGaD
Prazepam—GABRA5—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00148	0.00235	CbGpPWpGaD
Prazepam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00148	0.00446	CbGeAlD
Prazepam—GABRR2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00147	0.00233	CbGpPWpGaD
Prazepam—GABRA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00145	0.00231	CbGpPWpGaD
Prazepam—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00143	0.00227	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00142	0.00226	CbGpPWpGaD
Prazepam—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00139	0.00221	CbGpPWpGaD
Prazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00138	0.0022	CbGpPWpGaD
Prazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00136	0.00217	CbGpPWpGaD
Prazepam—Mazindol—SLC6A4—attention deficit hyperactivity disorder	0.00134	0.033	CrCbGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00132	0.0021	CbGpPWpGaD
Prazepam—GABRR1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0013	0.00206	CbGpPWpGaD
Prazepam—GABRR2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00126	0.00201	CbGpPWpGaD
Prazepam—GABRR2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00124	0.00197	CbGpPWpGaD
Prazepam—GABRR1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00124	0.00197	CbGpPWpGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00123	0.00196	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00122	0.00194	CbGpPWpGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00121	0.00192	CbGpPWpGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00119	0.00189	CbGpPWpGaD
Prazepam—GABRR2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00118	0.00188	CbGpPWpGaD
Prazepam—GABRR1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00118	0.00187	CbGpPWpGaD
Prazepam—GABRR2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00117	0.00187	CbGpPWpGaD
Prazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00116	0.00185	CbGpPWpGaD
Prazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00113	0.0018	CbGpPWpGaD
Prazepam—GABRR2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00112	0.00179	CbGpPWpGaD
Prazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00111	0.00177	CbGpPWpGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0011	0.00174	CbGpPWpGaD
Prazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00109	0.00173	CbGpPWpGaD
Prazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00108	0.00172	CbGpPWpGaD
Prazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00106	0.00169	CbGpPWpGaD
Prazepam—GABRR2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00105	0.00166	CbGpPWpGaD
Prazepam—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00104	0.00166	CbGpPWpGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00104	0.00165	CbGpPWpGaD
Prazepam—Amoxapine—DRD4—attention deficit hyperactivity disorder	0.00103	0.0254	CrCbGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00102	0.00163	CbGpPWpGaD
Prazepam—GABRG3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00102	0.00162	CbGpPWpGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00102	0.00162	CbGpPWpGaD
Prazepam—GABRR1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00101	0.00161	CbGpPWpGaD
Prazepam—GABRB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.001	0.0016	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000992	0.00158	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000988	0.00157	CbGpPWpGaD
Prazepam—GABRG3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000972	0.00155	CbGpPWpGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00097	0.00154	CbGpPWpGaD
Prazepam—GABRR2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000966	0.00154	CbGpPWpGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000966	0.00154	CbGpPWpGaD
Prazepam—GABRB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000958	0.00152	CbGpPWpGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000953	0.00152	CbGpPWpGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000951	0.00151	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000947	0.00151	CbGpPWpGaD
Prazepam—GABRR1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000942	0.0015	CbGpPWpGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000932	0.00148	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00093	0.00148	CbGpPWpGaD
Prazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00093	0.00148	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000926	0.00147	CbGpPWpGaD
Prazepam—GABRR1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000925	0.00147	CbGpPWpGaD
Prazepam—Amoxapine—HTR1B—attention deficit hyperactivity disorder	0.000915	0.0226	CrCbGaD
Prazepam—GABRB1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000912	0.00145	CbGpPWpGaD
Prazepam—GABRR2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000898	0.00143	CbGpPWpGaD
Prazepam—GABRR2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000889	0.00141	CbGpPWpGaD
Prazepam—Amoxapine—DRD3—attention deficit hyperactivity disorder	0.000888	0.0219	CrCbGaD
Prazepam—GABRR2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000882	0.0014	CbGpPWpGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000874	0.00139	CbGpPWpGaD
Prazepam—Amoxapine—DRD1—attention deficit hyperactivity disorder	0.000872	0.0215	CrCbGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000861	0.00137	CbGpPWpGaD
Prazepam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000858	0.00136	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000853	0.00136	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000849	0.00135	CbGpPWpGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000848	0.00135	CbGpPWpGaD
Prazepam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000839	0.00134	CbGpPWpGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000834	0.00133	CbGpPWpGaD
Prazepam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000833	0.00133	CbGpPWpGaD
Prazepam—Amoxapine—SLC6A3—attention deficit hyperactivity disorder	0.000827	0.0204	CrCbGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00082	0.0013	CbGpPWpGaD
Prazepam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000818	0.0013	CbGpPWpGaD
Prazepam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000818	0.0013	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000814	0.0013	CbGpPWpGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000813	0.00129	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000813	0.00129	CbGpPWpGaD
Prazepam—Amoxapine—ADRA2A—attention deficit hyperactivity disorder	0.00081	0.02	CrCbGaD
Prazepam—Loxapine—DRD4—attention deficit hyperactivity disorder	0.000805	0.0198	CrCbGaD
Prazepam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000804	0.00128	CbGpPWpGaD
Prazepam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000801	0.00127	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0008	0.00127	CbGpPWpGaD
Prazepam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000799	0.00127	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000796	0.00127	CbGpPWpGaD
Prazepam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000795	0.00126	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000793	0.00126	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000793	0.00126	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00079	0.00126	CbGpPWpGaD
Prazepam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000784	0.00125	CbGpPWpGaD
Prazepam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000784	0.00125	CbGpPWpGaD
Prazepam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000781	0.00124	CbGpPWpGaD
Prazepam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000779	0.00124	CbGpPWpGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000775	0.00123	CbGpPWpGaD
Prazepam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000767	0.00122	CbGpPWpGaD
Prazepam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000762	0.00121	CbGpPWpGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000762	0.00121	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000757	0.0012	CbGpPWpGaD
Prazepam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000757	0.0012	CbGpPWpGaD
Prazepam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000748	0.00119	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000743	0.00118	CbGpPWpGaD
Prazepam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000743	0.00118	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00074	0.00118	CbGpPWpGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000732	0.00116	CbGpPWpGaD
Prazepam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00073	0.00116	CbGpPWpGaD
Prazepam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000729	0.00116	CbGpPWpGaD
Prazepam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000727	0.00116	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000726	0.00115	CbGpPWpGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000724	0.00115	CbGpPWpGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000721	0.00115	CbGpPWpGaD
Prazepam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000716	0.00114	CbGpPWpGaD
Prazepam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000715	0.00114	CbGpPWpGaD
Prazepam—Loxapine—HTR1B—attention deficit hyperactivity disorder	0.000715	0.0176	CrCbGaD
Prazepam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000714	0.00114	CbGpPWpGaD
Prazepam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000713	0.00113	CbGpPWpGaD
Prazepam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000709	0.00113	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000704	0.00112	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000699	0.00111	CbGpPWpGaD
Prazepam—Loxapine—DRD3—attention deficit hyperactivity disorder	0.000694	0.0171	CrCbGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000691	0.0011	CbGpPWpGaD
Prazepam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000686	0.00109	CbGpPWpGaD
Prazepam—Loxapine—DRD1—attention deficit hyperactivity disorder	0.000681	0.0168	CrCbGaD
Prazepam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000681	0.00108	CbGpPWpGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000679	0.00108	CbGpPWpGaD
Prazepam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000676	0.00108	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000675	0.00107	CbGpPWpGaD
Prazepam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00067	0.00107	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000663	0.00105	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000659	0.00105	CbGpPWpGaD
Prazepam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000654	0.00104	CbGpPWpGaD
Prazepam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000651	0.00104	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00065	0.00103	CbGpPWpGaD
Prazepam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00065	0.00103	CbGpPWpGaD
Prazepam—Loxapine—SLC6A3—attention deficit hyperactivity disorder	0.000646	0.0159	CrCbGaD
Prazepam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000639	0.00102	CbGpPWpGaD
Prazepam—Loxapine—ADRA2A—attention deficit hyperactivity disorder	0.000633	0.0156	CrCbGaD
Prazepam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000628	0.000999	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000624	0.000993	CbGpPWpGaD
Prazepam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000623	0.000991	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000623	0.000991	CbGpPWpGaD
Prazepam—Amoxapine—SLC6A4—attention deficit hyperactivity disorder	0.000618	0.0152	CrCbGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000616	0.00098	CbGpPWpGaD
Prazepam—Amoxapine—DRD2—attention deficit hyperactivity disorder	0.000615	0.0151	CrCbGaD
Prazepam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000613	0.000975	CbGpPWpGaD
Prazepam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000612	0.000973	CbGpPWpGaD
Prazepam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000605	0.000963	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000598	0.000952	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000597	0.000949	CbGpPWpGaD
Prazepam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000594	0.000946	CbGpPWpGaD
Prazepam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000594	0.000945	CbGpPWpGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000588	0.000935	CbGpPWpGaD
Prazepam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000584	0.000929	CbGpPWpGaD
Prazepam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000584	0.000928	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00058	0.000923	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000579	0.000922	CbGpPWpGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000578	0.000919	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000576	0.000916	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000574	0.000913	CbGpPWpGaD
Prazepam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000573	0.000912	CbGpPWpGaD
Prazepam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00057	0.000906	CbGpPWpGaD
Prazepam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00057	0.000906	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000563	0.000896	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000561	0.000892	CbGpPWpGaD
Prazepam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000559	0.00089	CbGpPWpGaD
Prazepam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000557	0.000886	CbGpPWpGaD
Prazepam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000555	0.000883	CbGpPWpGaD
Prazepam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000552	0.000879	CbGpPWpGaD
Prazepam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000548	0.000873	CbGpPWpGaD
Prazepam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000539	0.000858	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000536	0.000852	CbGpPWpGaD
Prazepam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00053	0.000843	CbGpPWpGaD
Prazepam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00052	0.000828	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000517	0.000823	CbGpPWpGaD
Prazepam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000508	0.000808	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000498	0.000792	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000492	0.000784	CbGpPWpGaD
Prazepam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000489	0.000778	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000486	0.000774	CbGpPWpGaD
Prazepam—Loxapine—SLC6A4—attention deficit hyperactivity disorder	0.000483	0.0119	CrCbGaD
Prazepam—Loxapine—DRD2—attention deficit hyperactivity disorder	0.00048	0.0118	CrCbGaD
Prazepam—Amoxapine—HTR2A—attention deficit hyperactivity disorder	0.000475	0.0117	CrCbGaD
Prazepam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000472	0.000751	CbGpPWpGaD
Prazepam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000469	0.000746	CbGpPWpGaD
Prazepam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000459	0.00073	CbGpPWpGaD
Prazepam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000455	0.000724	CbGpPWpGaD
Prazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000451	0.000718	CbGpPWpGaD
Prazepam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00045	0.000716	CbGpPWpGaD
Prazepam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000447	0.000711	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000444	0.000706	CbGpPWpGaD
Prazepam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000443	0.000704	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00044	0.000699	CbGpPWpGaD
Prazepam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000439	0.000699	CbGpPWpGaD
Prazepam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000437	0.000695	CbGpPWpGaD
Prazepam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000432	0.000687	CbGpPWpGaD
Prazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000431	0.000685	CbGpPWpGaD
Prazepam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000429	0.000682	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000377	0.0006	CbGpPWpGaD
Prazepam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000375	0.000596	CbGpPWpGaD
Prazepam—Loxapine—HTR2A—attention deficit hyperactivity disorder	0.000371	0.00914	CrCbGaD
Prazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000355	0.000564	CbGpPWpGaD
Prazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000349	0.000556	CbGpPWpGaD
Prazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000321	0.000511	CbGpPWpGaD
Prazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000298	0.000475	CbGpPWpGaD
Prazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00029	0.000461	CbGpPWpGaD
Prazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000285	0.000453	CbGpPWpGaD
Prazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00028	0.000445	CbGpPWpGaD
Prazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000278	0.000442	CbGpPWpGaD
Prazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000273	0.000434	CbGpPWpGaD
Prazepam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000258	0.00041	CbGpPWpGaD
Prazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000239	0.00038	CbGpPWpGaD
Prazepam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000172	0.000273	CbGpPWpGaD
Prazepam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00017	0.000271	CbGpPWpGaD
Prazepam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000169	0.000269	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.02e-05	0.000112	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.85e-05	7.71e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.85e-05	7.71e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.77e-05	7.59e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.43e-05	7.05e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.87e-05	6.16e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.69e-05	5.87e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.94e-05	4.67e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.92e-05	4.64e-05	CbGpPWpGaD
Prazepam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.26e-05	2e-05	CbGpPWpGaD
